Location
Areas of Expertise
About Me
Dr. Christine Kay is a retina specialist with a deep commitment to advancing care for inherited retinal diseases. She has a special interest in conditions such as Stargardt disease, Achromatopsia, and Usher syndrome, and is actively involved as an investigator in multiple clinical trials at Vitreoretinal Associates. Her work focuses on cutting-edge gene therapies and novel treatments for retinal degenerations, offering hope to patients with conditions that were once considered untreatable.
Previously an Assistant Professor at the University of Florida, Dr. Kay now serves as Affiliate faculty at the University of South Florida. She is a member of the Macula Society and the Retina Society, and has been recognized with an honor award from the American Society of Retina Specialists. Her clinical practice integrates the latest research, providing patients with access to innovative therapies and comprehensive management of complex retinal disorders.
With extensive experience in vitreoretinal surgery and medical retina, Dr. Kay offers specialized care for a wide range of retinal conditions, including age-related macular degeneration, diabetic retinopathy, and retinal vascular diseases. Her approach combines meticulous clinical evaluation with a personalized treatment plan, ensuring each patient receives the most advanced and appropriate care.
Training

Vitreoretinal Surgery
2011University of Iowa
Fellowship
Ophthalmology
2009University of South Florida
ResidencyTransitional Internship
2006Roanoke Carilion Memorial Hospital
Residency
Doctor of Medicine
2005University of Florida
Medical School
Bachelor of Arts in Neurobiology, magna cum laude
2001Harvard University
Undergraduate
Awards & Honors
ASRS Senior Honor Award
2018American Society of Retina Specialists
Inducted into Macula Society
2017Macula Society
Inducted into Retina Society
2017Retina Society
Honor Award
2012American Society of Retina Specialists
Publications & Press
Safety and Efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2 multicentre, open-label, unilateral dose escalation study
Lancet•2024Current Clinical Applications of In Vivo Gene Therapy with AAVs
Molecular Therapy•2021Residual foveal cone structure in CNGB3-associated achromatopsia
Investigative Ophthalmology & Visual Science•2016
Certifications & Licensure
- Licensed In
- FL, IA
- License Numbers
- ME99947, 38258


